RIPK1 anticorps (Middle Region)
Aperçu rapide pour RIPK1 anticorps (Middle Region) (ABIN926877)
Antigène
Voir toutes RIPK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Réactivité croisée
- Boeuf (Vache)
-
Purification
- Purified
-
Immunogène
- RIPK1 antibody was raised in rabbit using the middle region of RIPK1 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RIPK1 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this RIPK1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
-
Autre désignation
- RIPK1
-
Sujet
- FAK overexpression in human tumors provides a survival signal function by binding to RIP and inhibiting its interaction with the death receptor complex. Synonyms: Polyclonal RIPK1 antibody, Anti-RIPK1 antibody, receptor, TNFRSF-interacting serine-threonine kinase 1 antibody.
-
Pathways
- Signalisation NF-kappaB, Apoptose, Caspase Cascade in Apoptosis, Signalisation TLR, Activation of Innate immune Response, Inositol Metabolic Process, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling, SARS-CoV-2 Protein Interactome, Ubiquitin Proteasome Pathway
Antigène
-